AU7119187A - Ester prodrugs of dopamine-beta-hydroxylase inhibitors - Google Patents

Ester prodrugs of dopamine-beta-hydroxylase inhibitors

Info

Publication number
AU7119187A
AU7119187A AU71191/87A AU7119187A AU7119187A AU 7119187 A AU7119187 A AU 7119187A AU 71191/87 A AU71191/87 A AU 71191/87A AU 7119187 A AU7119187 A AU 7119187A AU 7119187 A AU7119187 A AU 7119187A
Authority
AU
Australia
Prior art keywords
dopamine
beta
ester prodrugs
hydroxylase inhibitors
hydroxylase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU71191/87A
Other versions
AU600480B2 (en
Inventor
James Simpson Frazee
Carl Kaiser
Lawrence Ivan Kruse
Stephen Torey Ross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of AU7119187A publication Critical patent/AU7119187A/en
Application granted granted Critical
Publication of AU600480B2 publication Critical patent/AU600480B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU71191/87A 1986-04-08 1987-04-08 Ester prodrugs of dopamine-beta-hydroxylase inhibitors Ceased AU600480B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/849,333 US4743613A (en) 1986-04-08 1986-04-08 Ester prodrugs of dopamine-β-hydroxylase, inhibitors, composition containing them, and method of using them to inhibit dopamine-β-hydroxylase activity
US849333 1986-04-08

Publications (2)

Publication Number Publication Date
AU7119187A true AU7119187A (en) 1987-10-15
AU600480B2 AU600480B2 (en) 1990-08-16

Family

ID=25305580

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71191/87A Ceased AU600480B2 (en) 1986-04-08 1987-04-08 Ester prodrugs of dopamine-beta-hydroxylase inhibitors

Country Status (7)

Country Link
US (1) US4743613A (en)
EP (1) EP0244956A1 (en)
JP (1) JPS62242669A (en)
AU (1) AU600480B2 (en)
DK (1) DK175287A (en)
PT (1) PT84624B (en)
ZA (1) ZA872482B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU615572B2 (en) * 1988-09-14 1991-10-03 Du Pont Merck Pharmaceutical Company, The Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762850A (en) * 1987-03-24 1988-08-09 Smithkline Beckman Corporation Dopamine-beta-hydroxylase inhibitors
US4835154A (en) * 1987-06-01 1989-05-30 Smithkline Beckman Corporation 1-aralykyl-5-piperazinylmethyl-2-mercaptoimidazoles and 2-alkylthioimidazoles and their use as dopamine-βhydroxylase inhibitors
US4882348A (en) * 1987-12-29 1989-11-21 Smithkline Beckman Corporation 2-(aminoalkylthio)imidazoles as dopamine-β-hydroxylase inhibitors
CA2002245A1 (en) * 1988-12-01 1990-06-01 Lawrence I. Kruse Dopamine-.beta.-hydroxylase inhibitors
SK279264B6 (en) * 1989-05-05 1998-08-05 Rhone-Poulenc Agrochimie 1-arylimidazoles, method of preparation thereof, use and agent containing 1-arylimidazoles
US5393913A (en) * 1993-03-03 1995-02-28 Rhone-Poulenc Inc. N-formylanilines
ES2899730T3 (en) 2012-03-07 2022-03-14 Mclean Hospital Corp Aminoquinoline derivatives and their uses

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695093A1 (en) * 1965-10-21 1970-12-10 Geigy Ag J R New imidazole derivatives
DE2259627A1 (en) * 1972-12-06 1974-06-12 Hoechst Ag IMIDAZOLYL- (2) -THIO-ALKANEIC ACID ESTERS AND THE PROCESS FOR THEIR PRODUCTION
DE2609645A1 (en) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim AMINOALKYLHETEROCYCLES
US4284641A (en) * 1977-08-26 1981-08-18 Burroughs Wellcome Co. Pharmaceutically active imidazole derivatives
US4340738A (en) * 1979-06-21 1982-07-20 Janssen Pharmaceutica, N.V. 2,3-Dihydro-imidazo[2,1-b]benzothiazoles
GB2096987B (en) * 1981-04-22 1984-04-04 Farmos Oy Substituted imidazole and imidazole derivatives and their preparation and use
US4487761A (en) * 1982-04-05 1984-12-11 Merck & Co., Inc. Dopamine β-hydroxylase inhibitors
US4532331A (en) * 1983-04-12 1985-07-30 Smithkline Beckman Corporation 1-Benzyl-2-aminomethyl imidazole derivatives
PT78388B (en) * 1983-04-12 1986-09-15 Smithkline Beckman Corp Dopamine-beta-hydroxylase inhibitors
GB2141705B (en) * 1983-06-20 1986-09-24 Erba Farmitalia Imidazoles
US4719223A (en) * 1985-10-31 1988-01-12 Smithkline Beckman Corporation Imidazolethiol dopamine-beta-hydroxylase inhibitors

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU615572B2 (en) * 1988-09-14 1991-10-03 Du Pont Merck Pharmaceutical Company, The Antihypercholesterolemic 4,5-diaryl-2-substituted thioimidazoles

Also Published As

Publication number Publication date
PT84624A (en) 1987-05-01
EP0244956A1 (en) 1987-11-11
US4743613A (en) 1988-05-10
JPS62242669A (en) 1987-10-23
DK175287A (en) 1987-10-09
PT84624B (en) 1989-11-30
DK175287D0 (en) 1987-04-06
AU600480B2 (en) 1990-08-16
ZA872482B (en) 1988-02-24

Similar Documents

Publication Publication Date Title
AU546872B2 (en) Skin treatment compositions containing a fatty acid or ester
AU651804B2 (en) New esters of alginic acid
AU7960087A (en) Cross-linked ester of hyaluronic acid
AU583963B2 (en) Phosphoric ester compound
AU1875988A (en) 5-aralkyl-2-mercaptoimidazole derivatives as dopamine-beta- hydroxylase inhibitors
AU8307882A (en) C10-22 alkyl ester of tyrosine
AU1644788A (en) Dopamine-beta-hydroxylase inhibitors
AU3867585A (en) Esters of p-dimethylamino-cinnamic acid
AU6201386A (en) Preparation of esters
AU7119187A (en) Ester prodrugs of dopamine-beta-hydroxylase inhibitors
AU6032886A (en) Guanidinobenzoyl esters
AU580855B2 (en) Alkeneamidocephalosporin esters
AU6463986A (en) Dopamine-beta-hydroxylase inhibitors
AU1258988A (en) Esters of oxalofluoride
AU2936889A (en) 2-aminoalkylthioimidazoles as dopamine-beta-hydroxylase inhibitors
AU8135782A (en) Phosphoric nphosphonic acid ester amides
AU1003188A (en) Dopamine-beta-hydroxylase inhibitors
AU1370688A (en) Dopamine-beta-hydroxylase inhibitors
AU2911389A (en) 1-aralkyl-2-mercaptoimidazolines as dopamine-beta-hydroxylase inhibitors
AU6321086A (en) Esters of dihydrolysergic acid
AU8694291A (en) Ester inhibitors
AU2591984A (en) Ester of tricyclohexyl-tin hydroxide
AU6463886A (en) Dopamine-beta-hydroxylase inhibitors
AU4553889A (en) Dopamine-beta-hydroxylase inhibitors
AU589053B2 (en) Preparation process of alpha-l-aspartyl-l-phenyl-alanine methyl ester having low hygroscopicity